✦ LIBER ✦

Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma

✍ Scribed by Manzur, S.; Cohen, S.; Haimovich, J.; Hollander, N.

Book ID: 119833862
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 516 KB
Volume: 170
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.2012.04658.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced efficacy of gemcitabine in comb

Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell linesin vitroand inscidmice

✍ Mitchell R Smith; Indira Joshi; Fang Jin; Coleman Obasaju 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 554 KB

74 POSTER Experimental therapeutic appro

74 POSTER Experimental therapeutic approach of human diffuse large B-cell lymphoma xenografts by doxycycline, alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ F. Assayag; N. Brousse; J. Couturier; E. Macintyre; C. Mathiot; L. De Plater; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

71-P: A longitudinal analysis of transpl

71-P: A longitudinal analysis of transplant recipients treated with rituximab (anti-CD20): B cell ablation is not effective in depleting pre-existing anti-HLA class I or class II antibodies

✍ Allison Gasiewski; Erin Pierce; Jane Kearns; Eline Luning Prak; Simin Goral; Ald 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB